Macrophage plasticity and polarization: Cell signaling mechanisms and roles in immunity

Handbook of Macrophages: Life Cycle, Functions and Diseases

Volumn , Issue , 2012, Pages 147-174

  Paletta Silva, Rafael ^a   Meyer Fernandes, José Roberto ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84896200407     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (88)

1. Antoniv, T. T. Ivashkiv, L. B. (2011). Interleukin-10-induced gene expression and suppressive function are selectively modulated by the PI3K-Akt-GSK3 pathway. Immunology, 132, 567-577.
2. Araki, N. Johnson, M. T. Swanson, J. A. (1996). A role for phosphoinositide 3-kinase in the completion of macropinocytosis and phagocytosis by macrophages. The journal of cell biology, 135, 1249-1260.
3. Baron, M. Davignon, J. L. (2008). Inhibition of IFN-gamma-induced STAT1 tyrosine phosphorylation by human CMV is mediated by SHP2. Journal of immunology, 181, 5530-5536.
4. Baud, V. Karin, M. (2001). Signal transduction by tumor necrosis factor and its relatives. Trends in cell biology, 11, 372-377.
5. Benoit, M. Desnues, B. Mege, J. L. (2008). Macrophage polarization in bacterial infections. Journal of immunology, 181, 3733-3739.
6. Bertholet, S. Dickensheets, H. L. Sheikh, F. Gam, A. A. Donnelly, R. P. Kenney, R. T. (2003). Leishmania donovani-induced expression of suppressor of cytokine signaling 3 in human macrophages: a novel mechanism for intracellular parasite suppression of activation. Infection and immunity, 71, 2095-2101.
7. Biswas, S. K and Mantovani, A. (2010). Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm, Nature immunology. 11, 889-896.
8. Boehm, U. Klamp, T. Groot, M. Howard, J. C. (1997). Cellular responses to interferongamma. Annual review of immunology, 15, 749-795.
9. Bosschaerts, T. Morias, Y. Stijlemans, B. Hérin, M. Porta, C. Sica, A. Mantovani, A. De Baetselier, P. Beschin, A. (2011). IL-10 limits production of pathogenic TNF by M1 myeloid cells through induction of nuclear NF-κB p50 member in Trypanosoma congolense infection-resistant C57BL/6 mice. European journal of immunology, 41, 3270-3280.
10. Cassatella, M. A. Bazzoni, F. Flynn, R. M. Dusi, S. Trinchieri, G. Rossi, F. (1990). Molecular basis of interferon-gamma and lipopolysaccharide enhancement of phagocyte respiratory burst capability. Studies on the gene expression of several NADPH oxidase components. The journal of biological chemistry, 265, 20241-20246.
11. Chan, M. M. Evans, K. W. Moore, A. R. Fong, D. (2010). Peroxisome proliferator-activated receptor (PPAR): balance for survival in parasitic infections. Journal of biomedicine and biotechnology, 2010:828951.
12. Chawla, A. (2010). Control of macrophage activation and function by PPARs. Circulation research, 106, 1559-1569.
13. Chen, G. Shaw, M. H. Kim, Y. G. Nuñez, G. (2009). NOD-like receptors: role in innate immunity and inflammatory disease. Annual review of pathology, 4, 365-398.
14. Chung, E. Y, Kim, B. H. Hong, J. T. Lee, C. K. Ahn, B. Nam, S. Y. Han, S. B. Kim, Y. (2011). Resveratrol down-regulates interferon-γ-inducible inflammatory genes in macrophages: molecular mechanism via decreased STAT-1 activation. Journal of the nutritional biochemistry, 22, 902-909.
15. Das, P. Lahiri, A. Lahiri, A. Chakravortty, D. (2010). Modulation of the arginase pathway in the context of microbial pathogenesis: a metabolic enzyme moonlighting as an immune modulator. PLoS Pathogens, 6:e1000899.
16. Dickensheets, H. L. Venkataraman, C. Schindler, U. Donnelly, R. P. (1999). Interferons inhibit activation of STAT6 by interleukin 4 in human monocytes by inducing SOCS-1 gene expression. Proceedings of the National Academy of Science of the United States of America, 96, 10800-10805.
17. Dickensheets, H. L. Venkataraman, C. Schindler, U. Donnelly, R. P. (1996). Interferons inhibit activation of STAT6 by interleukin 4 in human monocytes by inducing SOCS-1 gene expression. Proceeding of the national academy of science of United States of America, 96, 10800-10805.
18. Dirkx, A. E. Oude Egbrink, M. G. Wagstaff, J. Griffioen, A. W. (2006). Monocyte/macrophage infiltration in tumors: modulators of angiogenesis. The journal of leukocyte biology, 80, 1183-1196.
19. Fang, F. C. (2004). Antimicrobial reactive oxygen and nitrogen species: concepts and controversies. Nature reviews. Microbiology, 2, 820-832.
20. Garrido, V. V. Dulgerian, L. R. Stempin, C. C. Cerbán, F. M. (2011). The increase in mannose receptor recycling favors arginase induction and trypanosoma cruzi survival in macrophages. International journal of biological sience, 7, 1257-1272.
21. Gasparoto, T. H. Tessarolli, V. Garlet, T. P. Torres, S. A. Garlet, G. P. da Silva, J. S. Campanelli, A. P. (2010). Absence of functional TLR4 impairs response of macrophages after Candida albicans infection. Medical Mycology, 48, 1009-1017.
22. Glass, C. K. Saijo, K. (2010). Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells. Nature reviews. Immunology. 10, 365-376.
23. Goerdt, S. Politz, O. Schledzewski, K. Birk, R. Gratchev, A. Guillot, P. Hakiy, N. Klemke, C. D. Dippel, E. Kodelja, V. Orfanos, C. E. (1999). Alternative versus classical activation of macrophages. Pathobiology, 67, 222-226.
24. Gordon, S. Taylor, P. R. (2005). Monocyte and macrophage heterogeneity. Nature reviews. Immunology, 5, 953-964.
25. Gu, Y. Kuida, K. Tsutsui, H. Ku, G. Hsiao, K. Fleming, M. A. Hayash N. Higashino, K. Okamura, H. Nakanishi, K. Kurimoto, M. Tanimoto, T. Flavell, R. A. Sato, V. Harding, M. W. Livingston, D. J. Su, M. S. (1997). Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme. Science, 275, 206-209.
26. Guruvayoorappan, C. (2008). Tumor versus tumor-associated macrophages: how hot is the link? Integrative cancer therapy, 7, 90-95.
27. Herrero, C. Hu, X. Li, W. P. Samuels, S. Sharif, M. N. Kotenko, S. Ivashkiv, L. B. (2003). Reprogramming of IL-10 activity and signaling by IFN-gamma. Journal of immunology, 171, 5034-5041.
28. Hsu, H. Xiong, J. Goeddel, D. V. (1995). The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation. Cell, 81, 495-504.
29. Hu, X. Ivashkiv, L. B. (2009). Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases. Immunity, 16, 539-550.
30. Kämper, N. Franken, S. Temme, S. Koch, S. Bieber, T. Koch, N. (2011). {gamma}-Interferon-regulated chaperone governs human lymphocyte antigen class II expression. FASEB Journal. doi: 10.1096/fj.11-189670.
31. Kanneganti, T. D. Lamkanfi, M. Núñez, G. (2007). Intracellular NOD-like receptors in host defense and disease. Immunity, 27, 549-559.
32. Kawai, T. and Akira, S. (2006). TLR signaling. Cell death and differentiation, 13, 816-825.
33. Kawai, T. Akira, S. (2011). Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity, 34, 637-50.
34. Kersse, K. Bertrand, M. J. Lamkanfi, M. Vandenabeele, P. (2011). NOD-like receptors and the innate immune system: Coping with danger, damage and death. Cytokine growth factor reviews, 22, 257-276.
35. Kropf, P. Fuentes, J. M. Fähnrich, E. Arpa, L. Herath, S. Weber, V. Soler, G. Celada, A. Modolell, M. Müller, I. (2005). Arginase and polyamine synthesis are key factors in the regulation of experimental leishmaniasis in vivo. FASEB Journal, 19, 1000-1002.
36. Kumar, H. Kawai, T. Akira, S. (2009). Toll-like receptors and innate immunity. Biochemical and biophysical research communication, 388, 621-625.
37. Kumar, H. Kawai, T. Akira, S. (2011). Pathogen recognition by the innate immune system. International reviews of immunology, 30, 16-34.
38. Lahiri, A. Das, P. Chakravortty, D. (2008). Arginase modulates Salmonella induced nitric oxide production in RAW264.7 macrophages and is required for Salmonella pathogenesis in mice model of infection. Microbes and infections, 2008, 10, 1166-1174.
39. Le Bitoux, M. A. Stamenkovic, I. (2008). Tumor-host interactions: the role of inflammation. Histochemistry and cell biology, 130, 1079-1090.
40. Magez, S. Radwanska, M. Drennan, M. Fick, L. Baral, T. N. Allie, N. Jacobs, M. Nedospasov, S. Brombacher, F. Ryffel, B. De Baetselier, P. (2007). Tumor necrosis factor (TNF) receptor-1 (TNFp55) signal transduction and macrophage-derived soluble TNF are crucial for nitric oxide-mediated Trypanosoma congolense parasite killing. Journal of infectious diseases, 196, 954-962.
41. Mäkelä, S. M. Strengell, M. Pietilä, T. E. Osterlund, P. Julkunen, I. (2009). Multiple signaling pathways contribute to synergistic TLR ligand-dependent cytokine gene expression in human monocyte-derived macrophages and dendritic cells. The journal of leukocyte biology, 85, 664-672.
42. Mantovani, A. Allavena, P. Sica, A. (2004). Tumour-associated macrophages as a prototypic type II polarised phagocyte population: role in tumour progression. European journal of cancer, 40, 1660-1667.
43. Martinez, F. O. (2011). Regulators of macrophage activation. European journal of immunology. 41, 1531-1534.
44. Martinez, F. O. Helming, L. Gordon, S. (2009). Alternative activation of macrophages: an immunologic functional perspective. Annual review of immunology, 27, 451-483.
45. Martinon, F. Burns, K. Tschopp, J. (2002). The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Molecular cell, 10, 417-426.
46. Michalik, L. Auwerx, J. Berger, J. P. Chatterjee, V. K. Glass, C. K. Gonzalez, F. J. Grimaldi, P. A. Kadowaki, T. Lazar, M. A. O'Rahilly, S. Palmer, C. N. Plutzky, J. Reddy, J. K. Spiegelman, B. M. Staels, B. Wahli, W. (2006). International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors. Pharmacological reviews, 58, 726-741.
47. Mohr, A. Chatain, N. Domoszlai, T. Rinis, N. Sommerauer, M. Vogt, M. Müller-Newen, G. (2011). Dynamics and non-canonical aspects of JAK/STAT signalling. European journal of cell biology, doi:10.1016/j.ejcb.2011.09.005.
48. Moore, K. W de Waal Malefyt, R. Coffman, R. L. O'Garra, A. (2001). Interleukin-10 and the interleukin-10 receptor. Annual review of immunology, 19, 683-765.
49. Morris, S. M. (2002). Regulation of enzymes of the urea cycle and arginine metabolism. Annual review of nutrition, 22, 87-105.
50. Morris, S. M. Jr. Kepka-Lenhart, D. Chen, L. C. (1998). Differential regulation of arginases and inducible nitric oxide synthase in murine macrophage cells. The American journal of physiology, 275:E740-7.
51. Mosser, D. M, Edwards, J. P. (2008). Exploring the full spectrum of macrophage activation. Nature reviews Immunology. 8, 958-969.
52. Mosser, D. M. (2003). The many faces of macrophage activation. Journal of leukocyte biology, 73, 209-212.
53. Moy, F. J. Diblasio, E. Wilhelm, J. Powers, R. (2001). Solution structure of human IL-13 and implication for receptor binding. Journal of molecular biology, 310, 219-230.
54. Munder, M. (2009). Arginase: an emerging key player in the mammalian immune system. British journal of pharmacology, 158, 638-651.
55. Nelms, K. Keegan, A. D. Zamorano, J. Ryan, J. J. Paul, W. E. (1999). The IL-4 receptor: signaling mechanisms and biologic functions. Annual review of immunology, 17, 701-738.
56. Nelson, S. M. Lei, X. Prabhu, K. S. (2011). Selenium levels affect the IL-4-induced expression of alternative activation markers in murine macrophages. The journal of nutrition, 141, 1754-1761.
57. Nguyen, V. T. Benveniste, E. N. (2000). Involvement of STAT-1 and ets family members in interferon-gamma induction of CD40 transcription in microglia/macrophages. The journal of biological chemistry, 275, 23674-23684.
58. Noori, S. Taghikhani, M. Hassan, Z. M. Allameha, A. Mostafaei, A. (2010). Tehranolide molecule modulates the immune response, reduce regulatory T cell and inhibits tumor growth in vivo. Molecular immunology, 47, 1579-1584.
59. O'Shea, J. J. Murray, P. J. (2008). Cytokine signaling modules in inflammatory responses. Immunity, 28, 477-487.
60. Parameswaran, N. Patial, S. (2010). Tumor necrosis factor-α signaling in macrophages. Critical reviews in eukaryotic gene Expression, 20, 87-103.
61. Pathak, S. K. Basu, S. Bhattacharyya, A. Pathak, S. Kundu, M. Basu, J. (2005). Mycobacterium tuberculosis lipoarabinomannan-mediated IRAK-M induction negatively regulates Toll-like receptor-dependent interleukin-12 p40 production in macrophages. The journal of biological chemistry, 280, 42794-42800.
62. Plüddemann, A. Mukhopadhyay, S. Gordon, S. (2011). Innate immunity to intracellular pathogens: macrophage receptors and responses to microbial entry. Immunology reviews, 240, 11-24.
63. Qiu, F. Maniar, A. Diaz, M. Q. Chapoval, A. I. Medvedev, A. E. (2011). Activation of cytokine-producing and antitumor activities of natural killer cells and macrophages by engagement of Toll-like and NOD-like receptors. Innate Immunity, 17, 375-387.
64. Reith, W. LeibundGut-Landmann, S. Waldburger, J. M. (2005). Regulation of MHC class II gene expression by the class II transactivator. Nature reviews. Immunology, 5, 793-806.
65. Romero, C. D. Varma, T. K. Hobbs, J. B. Reyes, A. Driver, B. Sherwood, E. R. (2011). The Toll-like receptor 4 agonist monophosphoryl lipid a augments innate host resistance to systemic bacterial infection. Infection and immunity, 79, 3576-3587.
66. Schenk, S. Hintermann, E. Bilban, M. Koshikawa, N. Hojilla, C. Khokha, R. Quaranta, V. (2003). Binding to EGF receptor of a laminin-5 EGF-like fragment liberated during MMP-dependent mammary gland involution. The journal of cell biology,161, 197-209.
67. Schroder, K. Hertzog, P. J. Ravasi, T. Hume, D. A. (2004). Interferon-gamma: an overview of signals, mechanisms and functions. Journal of leukocyte biology, 75, 163-189.
68. Sharda, D. R. Yu, S. Ray, M. Squadrito, M. L. De Palma, M. Wynn, T. A. Morris, S. M. Jr. Hankey, P. A. (2011). Regulation of macrophage arginase expression and tumor growth by the Ron receptor tyrosine kinase. Journal of immunology, 187, 2181-2192.
69. Shen, Y. Kawamura, I. Nomura, T. Tsuchiya, K. Hara, H. Dewamitta, S. R. Sakai, S. Qu, H. Daim, S. Yamamoto, T. Mitsuyama, M. (2010). Toll-like receptor 2- and MyD88-dependent phosphatidylinositol 3-kinase and Rac1 activation facilitates the phagocytosis of Listeria monocytogenes by murine macrophages. Infection and immunity. 78, 2857-2867.
70. Shimizu, T. (2010). Lipid mediators in health and disease: enzymes and receptors as therapeutic targets for the regulation of immunity and inflammation. Annual review of pharmacology and toxicology, 49, 123-50.
71. Shuai, K. Liu, B. (2003). Regulation of JAK-STAT signalling in the immune system. Nature reviews Immunology, 3, 900-911.
72. Silva, J. S. Vespa, G. N. Cardoso, M. A. Aliberti, J. C. Cunha, F. Q. (1995). Tumor necrosis factor alpha mediates resistance to Trypanosoma cruzi infection in mice by inducing nitric oxide production in infected gamma interferon-activated macrophages. Infection and immunity, 63, 4862-4867.
73. Siveen, K. S. Kuttan, G. (2009). Role of macrophages in tumour progression. Immunology letters, 123, 97-102.
74. Stein, M. Keshav, S. Harris, N. Gordon, S. (1992). Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. The journal of experimental medicine, 176, 287-292.
75. Stout, R. D. Jiang, C. Matta, B. Tietzel, I. Watkins, S.K. Suttles, J. (2005). Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences. Jorunal of immunology, 175, 342-349.
76. Sun, D. Ding, A. (2006). MyD88-mediated stabilization of interferon-gamma-induced cytokine and chemokine mRNA. Nature immunology, 7, 375-381.
77. Sweet, L. Singh, P. P. Azad, A. K. Rajaram, M. V. Schlesinger, L. S. Schorey, J. S. (2010). Mannose receptor-dependent delay in phagosome maturation by Mycobacterium avium glycopeptidolipids. Infection and Immunity, 78, 518-526.
78. Tartour, E. Pere, H. Maillere, B. Terme, M. Merillon, N. Taieb, J. Sandoval, F. Quintin-Colonna, F. Lacerda, K. Karadimou, A. Badoual, C. Tedgui, A. Fridman, W. H. Oudard, S. (2011). Angiogenesis and immunity: a bidirectional link potentially relevant for the monitoring of antiangiogenic therapy and the development of novel therapeutic combination with immunotherapy. Cancer metastasis reviews, 30, 83-95.
79. Valledor, A. F. Sánchez-Tilló, E. Arpa, L. Park, J. M. Caelles, C. Lloberas, J. Celada, A. (2008). Selective roles of MAPKs during the macrophage response to IFN-gamma. Journal of immunology, 180, 4523-4529.
80. Vázquez, N. Greenwell-Wild, T. Rekka, S. Orenstein, J. M. Wahl, S. M. (2006). Mycobacterium avium-induced SOCS contributes to resistance to IFN-gamma-mediated mycobactericidal activity in human macrophages. Journal of leukocyte biology, 80, 1136-1144.
81. Vilcek, J. (2006). Fifty years of interferon research: aiming at a moving target. Immunity, 25, 343-348.
82. Wajant, H. Pfizenmaier, K. Scheurich, P. (2003). Tumor necrosis factor signaling. Cell death and differentiation, 10, 45-65.
83. Wang, H. W. Joyce, J. A. (2010). Alternative activation of tumor-associated macrophages by IL-4: priming for protumoral functions. Cell Cycle, 9, 4824-4835.
84. Weigert, A. Sekar, D. Brüne, B. (2009). Tumor-associated macrophages as targets for tumor immunotherapy. Immunotherapy, 1, 83-95.
85. Woetmann, A. Brockdorff, J. Lovato, P. Nielsen, M. Leick, V. Rieneck, K. Svejgaard, A. Geisler, C. Ødum, N. (2003). Protein phosphatase 2A (PP2A) regulates interleukin-4-mediated STAT6 signaling. The journal of biological chemistry, 278, 2787-2791.
86. Yoshimura, A. (2006). Signal transduction of inflammatory cytokines and tumor development. Cancer science, 97, 439-447.
87. Zabaleta, J. McGee, D. J. Zea, A. H. Hernández, C. P. Rodriguez, P. C. Sierra, R. A. Correa, P. Ochoa, A. C. (2004). Helicobacter pylori arginase inhibits T cell proliferation and reduces the expression of the TCR zeta-chain (CD3zeta). Journal immunology, 173, 586-593.
88. Zhang, S. Kim, C. C. Batra, S. McKerrow, J. H. Loke, P. (2010). Delineation of diverse macrophage activation programs in response to intracellular parasites and cytokines. PLoS neglected tropical disease, 30, e648.